Monday 1 April 2019

Novartis pays $310 million upfront for inflammation specialist IFM

Novartis on Monday said it had agreed to pay $310 million upfront, with the possibility for more later, for some assets of Boston-based inflammation specialist IFM Therapeutics as the Swiss drugmaker seeks to expand its immunology pipeline.


from Reuters: Business News https://ift.tt/2HR4ibc

No comments:

Post a Comment

Tim Tully taught himself to code at age 6 and still codes daily. Here's how computer science took him from startups to AI investing at Menlo Ventures.

Tim Tully is a partner at Menlo Ventures. Menlo Ventures Tim Tully taught himself to code when he was six and went to school for comput...